DxNA

DxNA develops and manufactures high-value molecular diagnostic instruments, platforms, and tests, with a focus on the field of infectious diseases. The company's primary goal is to bring the benefits of molecular testing to underserved community hospitals and clinics, enabling easier and faster access to diagnostic information. The use of this information in a more timely manner has been proven to influence clinical decision-making, improve patient outcomes, and reduce treatment costs.